Cyclobenzaprine
AMRIX, Cyclobenzaprine Hydrochloride, Fexmid, TONMYA
Skeletal Muscle Relaxant
NADAC/unit
$0.0179
No Shortage
Tier 1: 79.3%
PA Req: 109.7%
15 Manufacturers
36 ANDAs
INDICATIONS AND USAGE Cyclobenzaprine hydrochloride tablets, USP are indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal c....
vs. brand AMRIX: Generic saves up to 100% per unit
Market Intelligence
2025-09-24 Class I Recall: Unichem Pharmaceuticals USA Inc.
Generic Manufacturers
ACTAVIS LABORATORIES FL INCAUROBINDO PHARMA LTDCHARTWELL RX SCIENCES LLCINVAGEN PHARMACEUTICALS INCJUBILANT CADISTA PHARMACEUTICALS INCKVK TECH INCMACLEODS PHARMACEUTICALS LTDNOVAST LABORATORIES LTDOXFORD PHARMACEUTICALS LLCPRINSTON PHARMACEUTICAL INCRISING PHARMA HOLDINGS INCRUBICON RESEARCH LTDTEVA PHARMACEUTICALS INTERNATIONAL GMBHTONIX PHARMACEUTICALS INCTP ANDA HOLDINGS LLCTWI PHARMACEUTICALS INCUNICHEM LABORATORIES LTD
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.